Literature DB >> 6806086

Diurnal oscillations in plasma protein binding of valproic acid.

I H Patel, R Venkataramanan, R H Levy, C T Viswanathan, L M Ojemann.   

Abstract

In view of the observed variation of valproic acid (VPA) free fraction (fp) during a dosing interval and the competitive binding effect of free fatty acids (FFA) in vitro, this study was designed to address the existence of diurnal variations in the fp of VPA. Six subjects were hospitalized at 7 a.m. for 25 h, and plasma samples were collected every 2 h. The protocol was repeated in 4 of the 6 subjects one week later. In vitro binding of VPA (100 micrograms/ml) was determined by equilibrium dialysis (14C-VPA), and FFAs were assayed colorimetrically. Phenytoin (PHT) binding was also determined for comparison. VPA fp ranged from 8.10 +/- 1.16 to 9.63 +/- 1.54. Intrasubject variability was also measured by the ratio of maximum to minimum fp values (fp max/fp min) over 24 h: This ratio ranged from 1.30 to 1.68 (mean +/- %SD = 1.51 +/- 7.7%, n = 10). For PHT, fp ranged from 10.88 +/- 0.50 to 12.39 +/- 1.07, and fp max/fp min from 1.09 to 1.31 (1.17 +/- 5.1%, n = 10). The fp max was observed between 2 and 6 a.m. in 7 out of 10 cases for VPA and 5 out of 10 cases for PHT. FFA levels, although in the normal range, varied two- to fourfold within 24 h. A significant correlation was observed between mean FFA levels at each sampling time and the corresponding fp values for VPA (p less than 0.001), but not for PHT.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806086     DOI: 10.1111/j.1528-1157.1982.tb06193.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

Review 1.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

Review 2.  Molecular clocks in pharmacology.

Authors:  Erik S Musiek; Garret A Fitzgerald
Journal:  Handb Exp Pharmacol       Date:  2013

3.  Divalproex to divalproex extended release conversion.

Authors:  Sandeep Dutta; Ronald C Reed
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 4.  Chronopharmacology of anti-convulsive therapy.

Authors:  Sriram Ramgopal; Sigride Thome-Souza; Tobias Loddenkemper
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.